Cafepharma Today

June 2 2023 - Novartis drug helps stop breast cancer’s return in large study
Novartis drug helps stop breast cancer’s return in large study
Pfizer says antibiotic is effective against tough-to-treat infections
Medicare outlines plan to expand coverage for costly new Alzheimer’s drugs
Supreme Court vetoes efforts to limit anti-fraud law aimed at government contractors
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings
Moderna vets help launch new RNA venture with $300M in largest financing round of 2023 so far
Fierce Biotech
Tuesday, May 23, 2023 - 9:59am
tags:
ReNAgade Therapeutics, RNA, Moderna Therapeutics, funding
Novo Nordisk’s trial of oral semaglutide meets primary endpoint
Clinical Trials Arena
Tuesday, May 23, 2023 - 9:56am
tags:
Novo Nordisk, semaglutide, oral semaglutide, clinical trials, weight loss
Here come the PD-1 agonists
EP Vantage
Tuesday, May 23, 2023 - 9:49am
tags:
PD-1 agonists, autoimmune disease, Eli Lilly, rheumatoid arthritis, peresolimab
New nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval
Stat
Monday, May 22, 2023 - 10:09pm
tags:
Opiant Pharmaceuticals, Opvee, FDA, opioid overdose, opioids, Fentanyl, Naloxone
Blueprint's Ayvakit picks up long-awaited FDA approval in indolent systemic mastocytosis
Fierce Pharma
Monday, May 22, 2023 - 10:07pm
tags:
Blueprint Medicines, Ayvakit, FDA, indolent systemic mastocytosis, systemic mastocytosis
6 Female Medtech Entrepreneurs You Need to Meet
Medical Devices and Diagnostics Industry
Monday, May 22, 2023 - 10:04pm
tags:
Medtech, women executives
Hepion Claims Phase II NASH Victory Following Intercept’s Adcomm Defeat
BioSpace
Monday, May 22, 2023 - 10:01pm
tags:
Hepion Pharmaceuticals, clinical trials, NASH, rencofilstat
Concentra rebounds from Jounce buy with a shot at COVID-19-focused Atea
Fierce Biotech
Monday, May 22, 2023 - 9:58pm
tags:
Concerta Biosciences, Atea Pharmaceuticals, M&A, COVID-19
Novo Nordisk pauses Wegovy marketing projects to dampen demand
Fierce Pharma
Monday, May 22, 2023 - 11:52am
tags:
Novo Nordisk, Wegovy, weight loss, DTC advertising
Pfizer Just Took Out $31 Billion in Debt. Here's Why That's Good News
Motley Fool
Monday, May 22, 2023 - 11:40am
tags:
Pfizer, debt, Seagen, M&A
Novartis to buy Avrobio gene therapy for $88M, leaving rest of the biotech on the shelf
Fierce Biotech
Monday, May 22, 2023 - 11:35am
tags:
Novartis, gene therapy, Avrobio, AVR-RD-04
Locate Bio receives FDA breakthrough designation for spinal fusion treatment
Biopharma Reporter
Monday, May 22, 2023 - 11:32am
tags:
Locate Bio, Orthopedics, FDA, LDGraft, spinal fusion, Medtech
Ironwood to buy VectivBio for $1.15 billion to boost digestive disorder drugs portfolio
Yahoo/Reuters
Monday, May 22, 2023 - 10:27am
tags:
Ironwood Pharmaceuticals, VectivBio, M&A, digestive disorders
Do medtech reps hate their colleagues in marketing?
Medical Devices and Diagnostics Industry
Monday, May 22, 2023 - 10:25am
tags:
Medtech, marketing, medtech reps
Sarepta Enters Uncharted Territory with Adcomm Approval
BioSpace
Monday, May 22, 2023 - 10:22am
tags:
Sarepta Therapeutics, SRP-9001, DMD, Duchenne Muscular Dystrophy, FDA, gene therapy
Thermo Fisher's biomarker blood tests to spot preeclampsia risk are first to win FDA nod
Fierce Biotech
Monday, May 22, 2023 - 10:19am
tags:
Thermo Fisher Scientific, diagnostics, Medtech, FDA, preeclampsia
Sanofi, Regeneron flesh out COPD data with Dupixent
Pharmaphorum
Monday, May 22, 2023 - 10:16am
tags:
Sanofi, Regeneron, COPD, Dupixent
Alnylam’s Onpattro succeeds in open-label ATTR cardiomyopathy extension
Clinical Trials Arena
Monday, May 22, 2023 - 10:11am
tags:
Alnylam Pharmaceuticals, Onpattro, clinical trials, transthyretin amyloidosis with cardiomyopathy
DMD gene therapy death exposes risks of treating older patients
Fierce Biotech
Monday, May 22, 2023 - 10:09am
tags:
Cure Rare Disease, gene therapy, clinical trials, DMD, patient deaths
Future of Intercept’s NASH drug in doubt after FDA panel rejection
BioPharma Dive
Sunday, May 21, 2023 - 10:51pm
tags:
Intercept Pharma, FDA, NASH, obeticholic acid

Pages

Latest CP Wire Articles

Eastman introduces new excipient to formulate poorly soluble API
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Klick Health launches new healthcare venture studio
Medtech earnings reports: insights from major players' Q4 results
Key compliance issues for medtech firms transitioning to data-enabled solutions
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

Latest Pharmagather Articles

The Drug Discount Ecosystem’s “Mission Critical”
Drug Channels
Fakin' It the Modern Way
In the Pipeline
Reduction of Tau
In the Pipeline
Timeless
In the Pipeline
Drug Channels News Roundup, May 2023: 340B Shame, OptumRx vs. Humira Biosimilars, ICER on White Bagging, Hospitals vs. Taxes, and Dr. G
Drug Channels
AI and the Hard Stuff
In the Pipeline
Break Out the Purple Carrots
In the Pipeline
Five (or Maybe Six?) Reasons that the Largest PBMs Operate Group Purchasing Organizations
Drug Channels
Give Me Those Hard, Hard Numbers
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information